| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Itandehui Castro-Quezada, Elena Flores-Guillén, Pilar E Núñez-Ortega, César A Irecta-Nájera, Xariss M Sánchez-Chino, Orquidia G Mendez-Flores, Zendy E Olivo-Vidal, Rosario García-Miranda, Roberto Solís-Hernández, Héctor Ochoa-Díaz-Lópe. Dietary Carbohydrates and Insulin Resistance in Adolescents from Marginalized Areas of Chiapas, México. Nutrients. vol 11. issue 12. 2020-08-24. PMID:31888175. |
evidence of the role that dietary carbohydrates (total carbohydrates, dietary fiber, total sugars, dietary glycemic index (gi) and glycemic load (gl)) exerts on insulin levels in adolescents is controversial. |
2020-08-24 |
2023-08-13 |
Not clear |
| Cristina Galarregui, María Ángeles Zulet, Irene Cantero, Bertha Araceli Marín-Alejandre, José Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Josep Antoni Tur, Itziar Abete, José Alfredo Martíne. Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile. International journal of molecular sciences. vol 19. issue 11. 2019-02-25. PMID:30463312. |
the aim of this study was to evaluate potential associations of dietary tac, gi, and gl with variables related to nutritive status and insulin resistance (ir) risk in cardiometabolic subjects. |
2019-02-25 |
2023-08-13 |
human |
| Niels K Porksen, Helle Linnebjerg, Eric Chen Quin Lam, Parag Garhyan, Alok Pachori, Richard E Pratley, Steven R Smit. Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus. Diabetes, obesity & metabolism. vol 20. issue 5. 2019-01-14. PMID:29316143. |
when treated with basal insulin peglispro (bil), patients with type 1 diabetes mellitus (t1dm) exhibit weight loss and lower prandial insulin requirements versus insulin glargine (gl), while total insulin requirements remain similar. |
2019-01-14 |
2023-08-13 |
human |
| S Pillai, S Duvvuru, P Bhatnagar, W Foster, M Farmen, S Shankar, C Harris, E Bastyr, B Hoogwerf, A Haup. The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro. The pharmacogenomics journal. vol 18. issue 3. 2019-01-11. PMID:29160303. |
in phase 3 trials, bil showed significantly improved glycemic control but higher levels of transaminases (alanine aminotransferase (alt) and aspartate aminotransferase (ast)), triglycerides (tgs) and liver fat content (lfc) compared with insulin glargine (gl). |
2019-01-11 |
2023-08-13 |
Not clear |
| Rakel F Johansen, Esben Søndergaard, Helle Linnebjerg, Parag Garhyan, Eric C Q Lam, Niels Porksen, Scott J Jacober, Søren Nielse. Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes. Diabetes, obesity & metabolism. vol 20. issue 2. 2018-12-27. PMID:28817248. |
to test the hypothesis that, as well as lowering weight and increasing plasma triglyceride (tg) levels and hepatic fat compared with insulin glargine (gl) in patients with type 1 diabetes, the attenuated peripheral effects of basal insulin peglispro (bil) may include increased free fatty acid flux to the liver, causing increased very-low-density lipoprotein (vldl)-tg secretion and lipid oxidation, and decreased tg adipose tissue deposition. |
2018-12-27 |
2023-08-13 |
Not clear |
| Guo Cheng, Hongmei Xue, Jiao Luo, Hong Jia, Lishi Zhang, Junbiao Dai, Anette E Buyke. Relevance of the dietary glycemic index, glycemic load and genetic predisposition for the glucose homeostasis of Chinese adults without diabetes. Scientific reports. vol 7. issue 1. 2018-08-28. PMID:28341844. |
adults in the highest gi (gl) tertile had an approximately 9% (5%) higher fasting plasma glucose, 11% (3%) higher glycated haemoglobin, 12% (7%) higher insulin level, and 28% (22%) higher hepatic insulin resistance compared to those in the lowest tertile (adjusted p |
2018-08-28 |
2023-08-13 |
Not clear |
| Lissé Angarita Dávila, José López Miranda, Daniel Aparicio Camargo, Karla Parra Zuleta, Maria Uzcátegui González, Virginia Céspedes Nava, Samuel Durán Agüero, Nadia Reyna Villasmi. Glycemic index, glycemic load and insulin response of two formulas of isoglucose with different sweeteners and dietary fiber in healthy adults and type-2 diabetes Nutricion hospitalaria. vol 34. issue 3. 2018-05-21. PMID:28627186. |
glycemic index, glycemic load and insulin response of two formulas of isoglucose with different sweeteners and dietary fiber in healthy adults and type-2 diabetes objective: the aim of this study is to compare the glycemic index (gi) and glycemic load (gl) of two formulas with the same glucose content with different sweeteners and dietary fiber for diabetics in healthy adults and in patients with type-2 diabetes (dm2).methodology: in this randomized, double-blind crossover research, eleven healthy people and six with dm2 consumed two enteral formulas, glucerna sr®, laboratorios abbott c.a. |
2018-05-21 |
2023-08-13 |
Not clear |
| Laura B Gualdrón-Duarte, Michael S Alle. Increased anaplerosis of the tricarboxylic acid cycle decreased meal size and energy intake of cows in the postpartum period. Journal of dairy science. vol 100. issue 6. 2018-05-03. PMID:28342606. |
compared with pa, gl increased plasma glucose and insulin concentrations for exp. |
2018-05-03 |
2023-08-13 |
Not clear |
| Cynthia Harris, Thomas Forst, Tim Heise, Leona Plum-Mörschel, Elaine Watkins, Qianyi Zhang, Ludi Fan, Parag Garhyan, Niels Porkse. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8. Diabetes technology & therapeutics. vol 19. issue 8. 2018-05-03. PMID:28817342. |
basal insulin peglispro (bil) has a peripheral-to-hepatic distribution of action that resembles endogenous insulin and a prolonged duration of action with a flat pharmacokinetic/pharmacodynamic profile at steady state, characteristics that tend to reduce hypoglycemia risk compared to insulin glargine (gl). |
2018-05-03 |
2023-08-13 |
Not clear |
| C Durão, A Oliveira, A C Santos, M Severo, A Guerra, H Barros, C Lope. Protein intake and dietary glycemic load of 4-year-olds and association with adiposity and serum insulin at 7 years of age: sex-nutrient and nutrient-nutrient interactions. International journal of obesity (2005). vol 41. issue 4. 2017-12-18. PMID:28028320. |
the current study evaluated the association of pi and gl at 4 years with adiposity and fasting serum insulin (fsi) 3 years later, and examined the possible interaction between pi and gl on these associations, by sex. |
2017-12-18 |
2023-08-13 |
Not clear |
| Niels Porksen, Helle Linnebjerg, Parag Garhyan, Eric C Q Lam, Mary P Knadler, Scott J Jacober, Ulrike Hoevelmann, Leona Plum-Moerschel, Elaine Watkins, Amalia Gastaldelli, Tim Heis. Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes. Diabetes, obesity & metabolism. vol 19. issue 4. 2017-11-02. PMID:27888561. |
in phase 3 trials, patients with t1dm treated with bil had lower prandial insulin requirements, yet improved prandial glucose control, relative to insulin glargine (gl). |
2017-11-02 |
2023-08-13 |
Not clear |
| R M Bergenstal, H Lunt, E Franek, F Travert, J Mou, Y Qu, C J Antalis, M L Hartman, M Rosilio, S J Jacober, E J Basty. Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3. Diabetes, obesity & metabolism. vol 18. issue 11. 2017-10-31. PMID:27265390. |
to compare the efficacy and safety of basal insulin peglispro (bil), which has a flat pharmacokinetic and pharmacodynamic profile and a long duration of action, with insulin glargine (gl) in patients with type 1 diabetes. |
2017-10-31 |
2023-08-13 |
Not clear |
| S Garg, M Dreyer, H Jinnouchi, J Mou, Y Qu, M L Hartman, M Rosilio, S J Jacober, E J Basty. A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1. Diabetes, obesity & metabolism. vol 18 Suppl 2. 2017-10-31. PMID:27393697. |
the primary objective was to demonstrate that basal insulin peglispro (bil) was non-inferior compared with insulin glargine (gl) for haemoglobin a1c (hba1c) at 26 weeks with a non-inferiority margin of 0.4%. |
2017-10-31 |
2023-08-13 |
Not clear |
| S Mudaliar, R R Henry, T P Ciaraldi, D A Armstrong, P M Burke, J H Pettus, P Garhyan, S L Choi, M P Knadler, E C Q Lam, M J Prince, N Bose, N K Porksen, V P Sinha, H Linnebjerg, S J Jacobe. Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes. Diabetes, obesity & metabolism. vol 18 Suppl 2. 2017-10-31. PMID:27723226. |
the current study compared the effects of bil and insulin glargine (gl) on endogenous glucose production (egp), glucose disposal rate (gdr) and lipolysis in patients with type 1 diabetes. |
2017-10-31 |
2023-08-13 |
Not clear |
| Adham Mottalib, Barakatun-Nisak Mohd-Yusof, Mohamed Shehabeldin, David M Pober, Joanna Mitri, Osama Hamd. Impact of Diabetes-Specific Nutritional Formulas versus Oatmeal on Postprandial Glucose, Insulin, GLP-1 and Postprandial Lipidemia. Nutrients. vol 8. issue 7. 2017-03-17. PMID:27455318. |
this study aims to evaluate postprandial (pp) effects of 2 dsnfs; glucerna (gl) and ultra glucose control (ugc) versus oatmeal (om) on glucose, insulin, glucagon-like peptide-1 (glp-1), free fatty acids (ffa) and triglycerides (tg). |
2017-03-17 |
2023-08-13 |
Not clear |
| Liyan Liu, Xinyang Wang, Ying Li, Changhao Su. Postprandial Differences in the Amino Acid and Biogenic Amines Profiles of Impaired Fasting Glucose Individuals after Intake of Highland Barley. Nutrients. vol 7. issue 7. 2016-03-22. PMID:26184292. |
after three different test loads, the area under the curve for glucose, insulin, lysine and gaba after a hb load decreased significantly compared to gl and wr loads. |
2016-03-22 |
2023-08-13 |
Not clear |
| Judith Karschin, Merit Lagerpusch, Janna Enderle, Ben Eggeling, Manfred J Müller, Anja Bosy-Westpha. Endocrine determinants of changes in insulin sensitivity and insulin secretion during a weight cycle in healthy men. PloS one. vol 10. issue 2. 2015-11-23. PMID:25723719. |
changes in insulin sensitivity (is) and insulin secretion occur with perturbations in energy balance and glycemic load (gl) of the diet that may precede the development of insulin resistance and hyperinsulinemia. |
2015-11-23 |
2023-08-13 |
human |
| R Steppa, K Szkudelska, J Wójtowski, M Stanisz, M Szumacher-Strabel, G Czyżak-Runowska, A Cieślak, M Markiewicz-Kęszycka, M Pietrza. The metabolic profile of growing lambs fed diets rich in unsaturated fatty acids. Journal of animal physiology and animal nutrition. vol 98. issue 5. 2015-06-01. PMID:24387699. |
glucose (gl), total cholesterol (ch), triglycerides (tg), free fatty acids (ffa), insulin (in), leptin (le), triiodothyronine (t3) and thyroxine (t4) were assayed in serum. |
2015-06-01 |
2023-08-12 |
Not clear |
| Lois Jovanovič, Anne L Peters, Honghua H Jiang, Dana S Hardi. Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes. Aging clinical and experimental research. vol 26. issue 2. 2015-02-19. PMID:24092662. |
the aim of this study was to compare durability of glycemic control of twice-daily insulin lispro mix 75/25 (lm75/25; 75 % insulin lispro protamine suspension, 25 % insulin lispro) and once-daily insulin glargine (gl) added to oral antihyperglycemic medications in older patients (≥65 years of age). |
2015-02-19 |
2023-08-12 |
Not clear |
| Darren C Greenwood, Diane E Threapleton, Charlotte E L Evans, Christine L Cleghorn, Camilla Nykjaer, Charlotte Woodhead, Victoria J Burle. Glycemic index, glycemic load, carbohydrates, and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies. Diabetes care. vol 36. issue 12. 2014-12-11. PMID:24265366. |
diets with high glycemic index (gi), with high glycemic load (gl), or high in all carbohydrates may predispose to higher blood glucose and insulin concentrations, glucose intolerance, and risk of type 2 diabetes. |
2014-12-11 |
2023-08-12 |
Not clear |